HepB
MASLD and HBV: How Concurrence May Paradoxically Protect and Worsen Disease
The prevalence of fatty liver disease has increased worldwide, and is particularly problematic among patients with ...
SEPTEMBER 11, 2024
HCV Elimination Program So Successful, Country of Georgia Tackles HBV
Program could serve as a model for others to tackle these viral diseases.
SEPTEMBER 6, 2024
‘Viral Hepatitis Is Not Gone—Not Yet’
About 1.2 million people around the world are infected with hepatitis B each year; the U.S. sees about 20,000 new ...
AUGUST 26, 2024
Increasing The Number of People Protected Against HBV
With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against ...
JUNE 15, 2023
All U.S. Adults Should Be Tested for HBV at Least Once
The CDC changed its recommendation for hepatitis B testing, because more than half the people who have HBV do not ...
MARCH 9, 2023
FDA Approves PreHevbrio 3-Antigen HepB Vaccine
PreHevbrio is indicated for the prevention of infection caused by all known subtypes of HBV in adults 18 years of ...
DECEMBER 3, 2021
ACIP Recommends ‘Universal’ Adult HBV Vaccine—But Not for All
The risk-based vaccination strategy has been partially successful with initial decreases, but new HBV infections ...
NOVEMBER 17, 2021
Grifols Introduces New Formulation of HepB IG to Treat Patients Exposed to Hepatitis B
Between 800,000 and 1.4 million Americans are infected with HBV. For unvaccinated patients, ACIP and CDC recommend ...
JUNE 26, 2021
USPSTF to Recommend HBV Screening for Pregnant Women
A proposed recommendation calls for screening all pregnant women for HBV at the first visit.
JANUARY 9, 2019
How Durable Is the Hepatitis B Vaccine?
Washington—About 85% of a cohort of Alaskans who received the hepatitis B vaccine at age 6 months or older ...
MAY 31, 2018
